ORIGINAL RESEARCH article

Front. Endocrinol., 06 August 2024

Sec. Obesity

Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1460652

This article is part of the Research TopicAdvances in the Research of Diabetic Nephropathy Volume IIIView all 5 articles

RETRACTED: Mendelian randomization based on immune cells in diabetic nephropathy

Retracted

A retraction of this article was approved in:

  1. Retraction: Mendelian randomization based on immune cells in diabetic nephropathy

    1. Read retraction
Ye Zhou&#x;Ye Zhou1†Hengyan Zhang&#x;Hengyan Zhang1†Heguo Yan,Heguo Yan1,2Changxing HuangChangxing Huang1Yangwen Liu*Yangwen Liu1*
  • 1Department of Endocrinology, Zhaotong Hospital of Traditional Chinese Medicine, Zhaotong, Yunnan, China
  • 2Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, Yunnan, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Zhou Y, Zhang H, Yan H, Huang C and Liu Y (2024) Mendelian randomization based on immune cells in diabetic nephropathy. Front. Endocrinol. 15:1460652. doi: 10.3389/fendo.2024.1460652

Received: 06 July 2024; Accepted: 22 July 2024;
Published: 06 August 2024; Retracted: 19 February 2025.

Edited by:

Yun Shen, Pennington Biomedical Research Center, United States

Reviewed by:

Yi Mu, ClinChoice Inc, United States
Jiayan Zhang, Los Angeles, United States
Hanxiao Sun, University of Texas Health Science Center at Houston, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.